NCT00379288View on ClinicalTrials.gov

Study of Mometasone Furoate/Formoterol Combination and Fluticasone/Salmeterol in Persistent Asthmatics Previously Treated With Inhaled Glucocorticosteroids (P04139)

PHASE3CompletedINTERVENTIONAL
Enrollment

404

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions
Asthma
Interventions
DRUG

mometasone furoate combination MDI 200/10 mcg BID

MF/F 200/10 mcg via a metered dose inhaler (MDI) twice daily for 1 year

DRUG

mometasone furoate combination MDI 400/10 mcg BID

MF/F 400/10 mcg via a metered dose inhaler (MDI) twice daily for 1 year

DRUG

Fluticasone/Salmeterol 250/50 mcg BID

F/SC 250/50 twice daily for 1 year

DRUG

Fluticasone/Salmeterol 500/50 mcg BID

F/SC 500/50 twice daily for 1 year

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00379288 - Study of Mometasone Furoate/Formoterol Combination and Fluticasone/Salmeterol in Persistent Asthmatics Previously Treated With Inhaled Glucocorticosteroids (P04139) | Biotech Hunter | Biotech Hunter